Provided by Tiger Trade Technology Pte. Ltd.

Exact Sciences

103.32
+0.14000.14%
Volume:2.67M
Turnover:275.59M
Market Cap:19.71B
PE:-19.63
High:103.36
Open:103.10
Low:103.06
Close:103.18
52wk High:103.42
52wk Low:38.81
Shares:190.81M
Float Shares:187.46M
Volume Ratio:1.01
T/O Rate:1.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.2638
EPS(LYR):-5.5856
ROE:-34.54%
ROA:-1.09%
PB:7.88
PE(LYR):-18.50

Loading ...

Assessing Exact Sciences (EXAS) Valuation After Oncotype DX Reaches 2 Million Patients

Simply Wall St.
·
Feb 08

Geneoscopy: Ptab's Ruling Concluded That All Claims of '746 Patent Challenged by Exact Sciences Before Ptab Are Unpatentable

THOMSON REUTERS
·
Feb 07

Geneoscopy: Ptab's Ruling Confirms Geneoscopy's Long-Held Position and Clears Path for Continued Commercialization of Colosense

THOMSON REUTERS
·
Feb 07

Exact Sciences ‘applauds’ passage of MCED legislation

TIPRANKS
·
Feb 04

BRIEF-German Cartel Office Approved Planned Acquisition Of Exact Sciences By Abbott

Reuters
·
Jan 30

German Cartel Office: Approved Planned Acquisition of Exact Sciences Corporation by Abbott Laboratories in Preliminary Proceedings

THOMSON REUTERS
·
Jan 30

Abbott Labs Stock Hits 52-Week Low As Outlook Disappoints

Benzinga
·
Jan 22

Abbott Q4 sales misses analyst expectations, hurt by diagnostics unit's challenges

Reuters
·
Jan 22

Abbott Labs Seen Posting Higher 4Q Sales Amid Pending Buyout of Exact Sciences -- Earnings Preview

Dow Jones
·
Jan 22

Exact Sciences Cut to Neutral From Outperform by Mizuho

Dow Jones
·
Jan 20

Mizuho Downgrades Exact Sciences to Neutral From Outperform, Adjusts Price Target to $105 From $85

MT Newswires Live
·
Jan 20

Exact Sciences Corp : Mizuho Cuts to Neutral From Outperform; Raises Target Price to $105 From $85

THOMSON REUTERS
·
Jan 20

Exact Sciences downgraded to Neutral from Outperform at Mizuho

TIPRANKS
·
Jan 20

FACTBOX-Major deals involving U.S. drugmakers and biotechs over the past decade

Reuters
·
Jan 15

Press Release: MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences

Dow Jones
·
Jan 12

Clinical Labs Hope to Head Off Looming Medicare Cuts -- Barrons.com

Dow Jones
·
Jan 10

Exact Sciences Sets February 20, 2026 Virtual Meeting for Shareholder Vote on $105-per-Share Abbott Merger

TIPRANKS
·
Jan 09

Exact Sciences Cut to In-Line From Outperform by Evercore ISI Group

Dow Jones
·
Jan 06

It’s Earnings Warning Season. How to Profit From Others’ Misery

Dow Jones
·
Jan 01

ADVISORY-Alert from law firm on Exact Sciences-Abbott deal withdrawn

Reuters
·
Dec 30, 2025